https://www.fda.gov/media/161378/download
Accenture Expects Q4 Revenue Of $15.75B-$16.35B Vs $16.35B Est; Reduces FY23 Revenue Growth to 8%-9%, (From Prior 8%-10%) Vs $64.41B Est, adj EPS of $11.52-$11.63 (From Prior $11.41-$11.63) Vs $11.6 Est
Business Outlook
Fourth Quarter Fiscal 2023
Accenture expects revenues for the fourth quarter of fiscal 2023 to be in the range of $15.75 billion to $16.35 billion, an increase
